Schedule 13G ownership disclosure

REATA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 75615P103

Event date: 2023-05-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,290,193
Percent of class
3.9100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-23-006552
Form type
SC 13G/A
Filer
First Light Asset Management, LLC
CIK
CIK 1600004
Filed
May 15, 2023
Reporting period
May 12, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub